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Background: Case management is a term used to describe the activities performed by a physician or
other health care professional to ensure the coordination of medical services required by a patient.
Managed care requires the incorporation of information pertaining to patient evaluation, treatment
planning, referrals, and follow-up care to ensure that payment for services is received and that care is
ongoing and comprehensive. The objective of this review was to assess the efﬁcacy of case management
in patients with type 2 diabetes mellitus with respect to outcomes such as glycosylated hemoglobin
(HbA1c), systolic blood pressure (SBP), diastolic blood pressure (DBP), and low-density lipoprotein (LDL).
Methods: Databases including PubMed, Embase, Web of Science, the Cochrane Library, the China Na-
tional Knowledge Infrastructure (CNKI), VIP, Wan Fang and the Chinese Biomedical Literature Database
(CBM) were searched for randomized controlled trials (RCTs) dating as late as Jan, 2015. Reference
sections of the included studies were also searched.
Results: Twelve studies, involving 11 RCTs that evaluated a total of 4000 patients, were included in this
analysis. Two of the 12 studies evaluated the same RCT. Seven of the 12 studies reported HbA1c as an
outcome, and three trials reported changes in SBP, DBP and LDL levels as outcomes. The pooled results
indicated that statistically signiﬁcant improvements in HbA1c (MD ¼ 0.35, 95% CI (0.68, 0.02),
P ¼ 0.04) and LDL levels (MD ¼ 2.49, 95% CI (4.04, 0.93), P ¼ 0.002) were associated with the case
management group compared with control group; however, no statistically signiﬁcant differences in DBP
(MD ¼ 0.08, 95% CI (0.68, 0.52), P ¼ 0.8) and SBP (MD ¼ 0.96, 95% CI (5.77, 3.84), P ¼ 0.69) were
observed.
Conclusions: Case management was effective in improving HbA1c and LDL levels in patients with type 2
diabetes mellitus. Although no statistically signiﬁcant differences in DBP and SBP between the case
management group and the control group were observed, further research is required to draw a
conclusion about the effect of managed care on these outcomes. Based on this meta-analysis of clinical
trials, we conclude that case management offers an effective clinical method for the treatment of type 2
diabetes.
© 2016 Shanxi Medical Periodical Press. Publishing services by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diabetes imposes a heavy burden on health-care systems and
on patients and their families. The World Health Organization
(WHO) reports that the worldwide prevalence of diabetes will
reach 366 million by 2030, with many new cases of diabetes
occurring in developing countries, especially in Southeast Asiaal Periodical Press.
blishing services by Elsevier B.V. Thand among the working class.1 Thus, the implementation of dia-
betes prevention programs and intervention programs to improve
glycemic control in people with diagnosed diabetes is a public
health problem worth prioritizing. The condition of impaired
glucose tolerance also represents a serious public health problem
that requires more attention. This is exempliﬁed by the fact that
approximately 70% of people with impaired glucose tolerance
have the potential to develop diabetes, and diabetes is associated
with an increased risk of cardiovascular disease. Many ethnic
minorities are at an increased risk of developing type 2 diabetesis is an open access article under the CC BY-NC-ND license (http://creativecommons.
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higher morbidity and mortality rates are associated with diabetes
in these populations.2,3 Therefore, it is imperative to identify
measures that address these serious problems. Case management
has been considered an effective approach for improving the
condition of diabetic patients. An earlier study4 reported the re-
sults of a meta-analysis evaluating the effect of case management
on HbA1cin patients with diabetes. The results demonstrated that
case management intervention was associated with substantial
improvements in HbA1c from baseline compared with control
groups4 that were not involved in a case management interven-
tion program. Many studies evaluating the effect of case man-
agement programs on HbA1c, however, are controversial.5e7
Furthermore, a systematic review of the effect of case manage-
ment speciﬁcally for patients with type 2 diabetes mellitus has
not been performed. Therefore, the aim of this meta-analysis was
to evaluate the effect of case management, as assessed by mul-
tiple treatment outcomes, in patients with type 2 diabetes. The
main objective of this review was to summarize the evidence
associated with the effect of case management on clinical out-
comes, such as HbA1c, SBP, DBP and LDL levels, in patients with
type 2 diabetes mellitus.
2. Methods
2.1. Inclusion criteria
2.1.1. Participants
Patients over the age of 18 years who were diagnosed with type
2 diabetes mellitus were included in this review. Ethnicity and
comorbidities were not parameters of the inclusion criteria.
2.1.2. Interventions
This analysis included studies employing multiple types of case
management intervention programs, such as telephone-based
intervention and face-to-face instruction.
2.2. Outcomes
2.2.1. Primary outcome
Glycated hemoglobin (HbA1c) measured after the intervention
phase was the primary outcome of this study.
2.2.2. Secondary outcomes
SBP, DBP, LDL, HDL, total cholesterol, and some additional vari-
ables were analyzed quantitatively or qualitatively, depending on
the variable being evaluated.
2.3. Study design
Randomized controlled studies meeting the inclusion criteria
were considered for analysis, regardless of the outcomes they
evaluated in the study.
2.4. Search strategy
We searched eight electronic databases, namely, PubMed,
Embase, Web of Science, CENTRAL, CNKI (China National Knowl-
edge Infrastructure), VIP, Wan Fang and CBM, using combinations
of Mesh and the following entry terms: “NIDDM”, “Maturity-Onset
Diabetes”, “Diabetes Mellitus, Noninsulin-Dependent”, “Diabetes
Mellitus, Adult-Onset”, “Adult-Onset Diabetes Mellitus”, “Diabetes
Mellitus, Adult Onset”, “Diabetes Mellitus, Ketosis-Resistant”,
“Diabetes Mellitus, Ketosis Resistant”, “Ketosis-Resistant Diabetes
Mellitus”, “Diabetes Mellitus, Maturity-Onset”, Diabetes Mellitus,“Non Insulin Dependent”, “Diabetes Mellitus, Non-Insulin-
Dependent”, “Non-Insulin-Dependent Diabetes Mellitus”,
“Diabetes Mellitus, Noninsulin Dependent”, “Diabetes Mellitus,
Slow-Onset”, “Diabetes Mellitus, Slow Onset”, “Slow-Onset Dia-
betes Mellitus”, “Diabetes Mellitus, Stable”, “Stable Diabetes Mel-
litus”, “Diabetes Mellitus, Type II”, “Maturity-Onset Diabetes
Mellitus”, “Maturity Onset Diabetes Mellitus”, “MODY”, “Type 2
Diabetes Mellitus”, “Noninsulin- Dependent Diabetes Mellitus”,
“type 2 Diabetes Mellitus”, “case management” and random. We
manually searched the references of included articles to identify
any additional relevant literature.
2.5. Review methods
The systematic review and meta-analysis was designed ac-
cording to guidelines described in the Cochrane Handbook for
Systematic Reviews of Interventions.8 Searches and data extrac-
tion were performed by two individual investigators (ZZ and ST).
Each trial identiﬁed in the search was evaluated for relevant do-
mains, including author, number of participants, year published,
allocation method, age of included patients, disease duration,
intervention and control measures, length of treatments, patient
inclusion and exclusion criteria, baseline values and outcome
measures. Any disagreement between investigators was resolved
through discussion with a third investigator (SGM). All remaining
articles were viewed as full text. A quality assessment of the trials
included in this study was performed independently by two re-
viewers according to the criteria described in the Cochrane
Handbook for Systematic Reviews of Interventions Version 5.1.0.8
Evaluation domains for the quality assessment included
randomization sequence generation, allocation concealment,
blinding of participants and study personnel, blinding of outcome
assessment, incomplete outcome data, selective reporting and
other biases. Based on the information extracted from the primary
studies, each parameter was rated as “high risk”, “unclear risk” or
“low risk”. All studies included in this meta-analysis were
reviewed for heterogeneity in clinical factors and methodology. If
clinical heterogeneity existed, data could not be combined. All
extracted data were entered into RevMan 5.3 (Copenhagen: The
Nordic Cochrane Centre, The Cochrane Collaboration, 2013) for
statistical analysis. All extracted data pertained to continuous
outcomes. If more than two treatment groups were evaluated,
data associated with the most intensive or effective intervention
group and with the control group were used for analysis. Standard
mean differences (SMDs) with 95% conﬁdence intervals (Cis) for
continuous outcomes were selected for calculating the pooled
effects. The I2 test was used to calculate the percentage of total
variation across studies due to heterogeneity. Values greater than
50% indicate a substantial level of heterogeneity. In the absence of
clinical heterogeneity and the presence of statistical heterogene-
ity (I2 greater than 60%), we used a random effects model. If
studies were similar enough to consider for pooled analysis, we
used a ﬁxed effect model for low to moderate levels of hetero-
geneity (I2 values were 0e60%).9
Endpoint data were used to calculate the summarized results.
Subgroup analysis was performed if any sources of heterogeneity
were identiﬁed.
3. Results
A total of 212 trials were identiﬁed in the initial literature search,
and an additional two studies were identiﬁed from other sources.
Twelve studies10e21 that included data from 11 clinical trials with a
total of 4000 participants were selected for further analysis ac-
cording to inclusion and exclusion criteria. The duration of these
Z. Zeng et al. / Chinese Nursing Research 3 (2016) 71e76 73studies was approximately 2 years, but it varied slightly among the
different studies. Among the selected studies, seven trials analyzed
quantitatively. The ﬂow diagram of the literature retrieval and se-
lection process is presented in Fig. 1.
Methodologies used in the included trials are presented in Fig. 2.3.1. Quantitative analysis
3.1.1. The effect of case management versus usual care on HbA1c
A total of 929 patients participated in the seven trials that re-
ported changes in HbA1c12,13,15e19,21 as a study outcome. There was
substantial heterogeneity among the seven trials (P < 0.00001,
I2 ¼ 86%); therefore, the random effects model of analysis was
used. The pooled results demonstrated that there was a statisti-
cally signiﬁcant difference in HbA1c associated with the case212 of records
identified 
through database
searching
2 of additional
records identified
through other
sources
112 of records after duplicates
removed
83 of records excluded
20 not RCT
37 unrelated with this topic
25 inappropriate with 
included criteria
1 non-English, non-Chinese
112  of records
screened
29 of full-text
articles assessed
for eligibility
12 of studies
included in
qualitative
synthesis
7 of studies
included in
quantitative
synthesis
(meta-analysis)
17 of full-text articles excluded
1 can not get the full-text
5 not RCT
7 protocol or design for RCT
4 inappropriate with included
criteria
Fig. 1. Flow chart of literature retrieval and selection.management study group compared with the control group
(MD ¼ 0.35, 95% CI (0.68, 0.02), P ¼ 0.04) (Fig. 3). No obvious
heterogeneity sources were identiﬁed, and therefore, subgroup
analysis cannot be performed.3.1.2. The effect of case management versus usual care on LDL
Three trials evaluating a total of 893 patients with type 2 dia-
betes reported change in LDL as an outcome of the study.12,13,16 No
substantial heterogeneity was detected in these studies (P ¼ 0.09,
I2 ¼ 59%); therefore, a ﬁxed-effects model of analysis was per-
formed to calculate the mean effect size. The analysis demonstrated
that a statistically signiﬁcant difference in LDL was associated with
the case management group compared with the usual care group
(MD ¼ 2.49, 95% CI (4.04, 0.93), P ¼ 0.002) (Fig. 4).3.1.3. The effect of case management versus usual care on SBP
Three trials evaluating a total of 893 patients reported changes
in SBP as an outcome of the study.12,13,16 Substantial heterogeneity
was detected among the studies (P ¼ 0.0006, I2 ¼ 87%); therefore,
the random effects model was employed. The results demonstrated
that no statistically signiﬁcant difference in SBP was associated
with the case management group compared with the control group
(MD ¼ 0.96, 95% CI (5.77, 3.84), P ¼ 0.69) (Fig. 5). However, the
case management group was associated with a numerically greater
decrease in SBP, indicating that this parameter might warrant
future investigation. Obvious heterogeneity sources were not
identiﬁed, and therefore, subgroup analysis cannot be performed.3.1.4. The effect of case management versus usual care on DBP
Three trials evaluating a total of 893 patients with type 2 dia-
betes reported changes in DBP as an outcome of the study.12,13,16 No
substantial heterogeneity was detected among the studies
(P ¼ 0.18, I2 ¼ 41%); therefore, a random effects model of analysis
was performed to calculate mean difference. The results demon-
strated that no statistically signiﬁcant difference in DBP was asso-
ciated with the case management group compared with the control
group (MD ¼ 0.08, 95% CI (0.68, 0.52), P ¼ 0.80) (Fig. 6). How-
ever, the case management group was associated with a numeri-
cally greater decrease in DBP, indicating that this parameter might
warrant future investigation.3.2. Qualitative analysis
Outcomes reported in only one of the studies included in this
analysis could not be used for comparative analyses. These out-
comes included total cholesterol, HDL, triglycerides, BMI, blood
glucose levels, quality of life, and compliance behaviors. The use of
case management for patients with type 2 diabetes demonstrated
promising effects on many of these outcomes. One study11
demonstrated that a relatively short period of case management
for patients with type 2 diabetes without clinically identiﬁable
retinopathy signiﬁcantly diminished the risk of these patients
developing retinopathy during the follow-up period. One study10
found that case management provided an advantage over stan-
dard provider care (SPC) with respect to patient compliance in
eating two or more servings of fresh fruit and vegetables per day.
One study14 found that improved diabetes control in the elderly
following a telemedicine case management intervention program
that followed existing guidelines was associated with less global
cognitive decline. This effect seemed to be mediated primarily by
improvements in HbA1c; however, more comprehensive evidence
is required to conﬁrm this ﬁnding.
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judgments regarding the risk of bias with respect to various parameters for individual studies.
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4.1. Reporting quality
With respect to the domain of random sequence generation,
one study was judged to present a high risk of bias due to the use of
incorrect randomization methods.19 Regarding the domain of
allocation concealment, two trials were rated as presenting a low
risk of bias due to the use of sealed envelopes.13,16,17 However, with
respect to the domains of blinding for participants and personnel
and blinding outcome assessment, 11 studies were judged as
presenting an unclear risk of bias,1e11 and one was rated as pre-
senting a high risk.21 Therefore, allocation concealment may have
been inﬂuenced, which could have led to performance and mea-
surement bias. With respect to the domain of incomplete outcome
data, ﬁve studies were judged as presenting a high risk of bias due
to a lack of detailed descriptions pertaining to drop-
outs.10,11,13,14,16,17 Regarding selective reporting, two RCTs were
judged to present a high risk of bias due to a failure to report all
required results.11,16,17 Finally, two studies were judged aspresenting a high risk of bias for using a pre-protocol (PP) principle
to analyze the results with exclusion bias, potentially leading to
overestimated results.10,16,17
4.2. Necessities
Recent data from the National Health and Nutrition Examina-
tion Survey (NHANES) 2003e2006 suggest that only 12.2% of
diabetes patients have simultaneous control of blood pressure
(BP), glycemia, and lipids. Case management using physician ex-
tenders (nurses, pharmacists, etc.) is a method that has previously
been used to improve risk factor control.22 Once considered a
disease of western society, type 2 diabetes mellitus (T2DM) has
now spread globally, and Asia accounts for approximately 60% of
the world's diabetic patients.23 Obesity and T2DM have become a
serious public health problem.24 Effective interventions must
integrate coordination of care and discharge planning into today's
best practice models.25 However, the effect of case management
for diabetic patients has demonstrated conﬂicting results. An
earlier study3 reported results of a meta-analysis evaluating the
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These results demonstrated a large effect size favoring case man-
agement intervention over control groups with respect to
improving HbA1c values from baseline.3 However, no systematic
review evaluating the efﬁcacy of case management in patients
with T2DM has been performed. This meta-analysis was con-
ducted to determine if case management provides advantages over
usual care for type 2 diabetic patients.
4.3. Limitations
4.3.1. Limitations for included literature
Questions regarding the effect of case management on type 2
diabetes mellitus still remain. Limitations of this study includecase management Control Me
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The most effective case management program with respect to
method and duration of time should be explored further. Case
management for type 2 diabetic patients could beneﬁt from
standardization and systematization efforts. Among the studies
included in this analysis, some case management programs were
employed in combination with additional methods such as com-
munity health work16 and motivational interviewing.12 A combi-
nation of approaches might produce different results compared
with case management alone. From this perspective, it could be
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method alone. While meaningful results for some outcomes were
obtained in this study, some outcomes could not be used for
pooled analysis due to a lack of sufﬁcient information. However,
some of these outcomes might be valuable for assessing the effects
of case management on factors such as the quality of life and
compliance behaviors. Furthermore, the studies included in this
analysis did not assess cost-effectiveness, which is considered as
an important factor in the real-world clinical setting.
4.3.2. Limitations of this review
Springer Link, ScienceDirect, and some other databases, were
not included in our search; therefore, there is a risk of partial se-
lection bias. In addition, the inclusion of only English and Chinese
literature may have resulted in selection bias for language limita-
tions, which potentially affected the credibility of the pooled results
of this study.
In conclusion, case management was proven to be effective in
improving HbA1c and LDL in patients with type 2 diabetes mellitus,
although no signiﬁcant differences in DBP and SBP were demon-
strated. We conclude that case management provides an effective
clinical strategy for patients with type 2 diabetes.
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